nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry
|
Chanswangphuwana, Chantiya |
|
|
22 |
10 |
p. e915-e921 |
artikel |
2 |
Consolidative Autologous Stem Cell Transplantation Versus Whole Brain Radiation in PCNSL; a Nationwide Analysis
|
Samhouri, Yazan |
|
|
22 |
10 |
p. 735-743 |
artikel |
3 |
Corrigendum to “P-196: Isatuximab Plus Carfilzomib and Dexamethasone in Patients With Relapsed Multiple Myeloma and Soft-Tissue Plasmacytomas: IKEMA Subgroup Analysis, Clinical Lymphoma Myeloma and Leukemia” [Vol21, Sup 2, Oct 2021, Pages S145-S146]
|
|
|
|
22 |
10 |
p. 785-786 |
artikel |
4 |
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia
|
Lee, Dasom |
|
|
22 |
10 |
p. 774-779 |
artikel |
5 |
“Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country”
|
Jobanputra, Kunal |
|
|
22 |
10 |
p. e898-e906 |
artikel |
6 |
Editorial Board
|
|
|
|
22 |
10 |
p. A1-A2 |
artikel |
7 |
Effect of Age and Socioeconomic Factors in the Utilization of Chemotherapy in Acute Lymphoblastic Leukemia (ALL): A SEER Database Study of 16,196 Patients
|
Joshi, Utsav |
|
|
22 |
10 |
p. e907-e914 |
artikel |
8 |
Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients
|
Gokmen, Ayla |
|
|
22 |
10 |
p. e885-e892 |
artikel |
9 |
Induction Therapy and Survival for Acute Myeloid Leukemia in Hispanic Adults from Puerto Rico
|
Castaneda-Avila, Maira A. |
|
|
22 |
10 |
p. e922-e930 |
artikel |
10 |
PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin Lymphoma
|
Thiruvengadam, Swetha Kambhampati |
|
|
22 |
10 |
p. e893-e897 |
artikel |
11 |
Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocytosis, and XIAP Gene Mutations: Getting the Treatment Right!
|
Guntiboina, Vinay Anand |
|
|
22 |
10 |
p. 780-784 |
artikel |
12 |
Prognostic Impact of Adiposity in Hematological Malignancies: A Systematic Review and Meta-analysis
|
Aleixo, Gabriel F.P. |
|
|
22 |
10 |
p. 726-734 |
artikel |
13 |
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis
|
Othman, Tamer |
|
|
22 |
10 |
p. e947-e957 |
artikel |
14 |
Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis
|
Naser, Abdallah Y. |
|
|
22 |
10 |
p. 760-773 |
artikel |
15 |
Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology
|
Jung, Eun Hee |
|
|
22 |
10 |
p. e931-e937 |
artikel |
16 |
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
|
Jacobs, Miriam T. |
|
|
22 |
10 |
p. 753-759 |
artikel |
17 |
SOHO State of the Art Updates and Next Questions | Novel Approaches to Pediatric T-cell ALL and T-Lymphoblastic Lymphoma
|
Summers, Ryan J |
|
|
22 |
10 |
p. 718-725 |
artikel |
18 |
SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma
|
Simard, Jillian |
|
|
22 |
10 |
p. 709-717 |
artikel |
19 |
Table of Contents
|
|
|
|
22 |
10 |
p. A3-A5 |
artikel |
20 |
The Impact of Sequence of Therapy for Older Patients With Follicular Lymphoma: SEER-Medicare Analysis
|
Xie, Can |
|
|
22 |
10 |
p. e938-e946 |
artikel |
21 |
Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders
|
Stubbins, Ryan J. |
|
|
22 |
10 |
p. 744-752 |
artikel |